Wall Street Journal |
New Implantable Pump Could Cut Diabetes Treatments
Wall Street Journal A diabetes drug delivered continuously from a small implantable pump resulted in a marked and sustained reduction in blood sugar in patients in two studies, potentially setting the stage for a once-a-year treatment option to manage the disease. Intarcia's annual diabetes treatment aces two Phase III trialsFierceBiotech Boston company touts trial results of potentially revolutionary Type 2 …Boston Business Journal (blog) Boston company touts diabetes pump as major breakthroughEnterprise News (blog) myCentralOregon.com –NEWS.GNOM.ES all 26 news articles » |
More details can be found at www.diabeteshowto.com
Discussion
Comments are disallowed for this post.
Comments are closed.